Primary Angle-Closure Glaucoma
Conditions
Interventions
Experimental Group:CLASS Combined with Phacoemulsification
Control Group:Trabeculectomy Combined with Phacoemulsification
Sponsors
Shanghai First People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) When screening, the studied eye was diagnosed with chronic angle closure glaucoma with cataract, and the IOP was more than 21 mmHg after the maximum tolerance drug treatment; 2) When screening, the studied eye was diagnosed with acute angle closure glaucoma with chronic stage and remission combined with cataract. The IOP was greater than 21 mmHg after the maximum tolerance drug treatment.
Exclusion criteria
Exclusion criteria: 1) At baseline, the studied eye had any active intraocular or periocular infection/ active intraocular inflammation (e.g., infectious conjunctivitis, keratitis, scleritis, endophthalmitis, infectious blepharitis, uveitis); 2) The late stage of primary angle closure glaucoma, the severely damaged optic nerve, C / D >=0.8; 3) neovascular glaucoma (NVG), secondary glaucoma with uncontrollable inflammation, ocular surgery history, monocular blindness, and diopter opacity affecting the evaluation of optic nerve.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the reduction of postoperative intraocular pressure after CLASS combined with phacoemulsification compared with trabeculectomy combined with phacoemulsification; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes of best corrected visual acuity after CLASS combined with phacoemulsification compared with trabeculectomy combined with phacoemulsification;The complete success rate of CLASS combined with phacoemulsification vs trabeculectomy combined with phacoemulsification;The conditional success rate of CLASS combined with phacoemulsification vs trabeculectomy combined with phacoemulsification;The average number of anti glaucoma drugs after class combined with phacoemulsification compared with trabeculectomy combined with phacoemulsification;The morphology of filtering bleb after trabeculectomy combined with phacoemulsification in the treatment of class combined with phacoemulsification;intraoperative complications of class combined with phacoemulsification and trabeculectomy combined with phacoemulsification;Postoperative complications of class combined with phacoemulsification and trabeculectomy combined with phacoemulsification; | — |
Countries
China
Contacts
Public ContactHaiyan Wang
Outcome results
None listed